GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cordlife Group Ltd (SGX:P8A) » Definitions » PB Ratio

Cordlife Group (SGX:P8A) PB Ratio : 0.27 (As of Jun. 07, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Cordlife Group PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-07), Cordlife Group's share price is S$0.14. Cordlife Group's Book Value per Share for the quarter that ended in Dec. 2023 was S$0.53. Hence, Cordlife Group's PB Ratio of today is 0.27.

The historical rank and industry rank for Cordlife Group's PB Ratio or its related term are showing as below:

SGX:P8A' s PB Ratio Range Over the Past 10 Years
Min: 0.23   Med: 1.04   Max: 4.13
Current: 0.26

During the past 12 years, Cordlife Group's highest PB Ratio was 4.13. The lowest was 0.23. And the median was 1.04.

SGX:P8A's PB Ratio is ranked better than
99.01% of 203 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.07 vs SGX:P8A: 0.26

During the past 12 months, Cordlife Group's average Book Value Per Share Growth Rate was 0.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 0.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 1.10% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 3.90% per year.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Cordlife Group was 26.90% per year. The lowest was -6.70% per year. And the median was 1.20% per year.

Back to Basics: PB Ratio


Cordlife Group PB Ratio Historical Data

The historical data trend for Cordlife Group's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordlife Group PB Ratio Chart

Cordlife Group Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.93 0.76 0.75 0.61 0.60

Cordlife Group Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.66 0.61 1.05 0.60

Competitive Comparison of Cordlife Group's PB Ratio

For the Diagnostics & Research subindustry, Cordlife Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cordlife Group's PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cordlife Group's PB Ratio distribution charts can be found below:

* The bar in red indicates where Cordlife Group's PB Ratio falls into.



Cordlife Group PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Cordlife Group's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.14/0.528
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Cordlife Group  (SGX:P8A) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Cordlife Group PB Ratio Related Terms

Thank you for viewing the detailed overview of Cordlife Group's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cordlife Group (SGX:P8A) Business Description

Traded in Other Exchanges
Address
1 Yishun Industrial Street 1, Number 06-01/09, A'Posh Bizhub, Singapore, SGP, 768160
Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Cordlife has processing and storage facilities in six key markets across Asia, namely Singapore, Hong Kong, Malaysia, India, Indonesia, and the Philippines. The company has two segments - The Banking segment, comprises cord blood, cord lining, and cord tissue services. The Diagnostics segment comprises Metascreen, which is a non-invasive metabolic screening test specially designed for newborn babies, non-invasive prenatal testing service and Eyescreen, a paediatric eye-screening service.

Cordlife Group (SGX:P8A) Headlines

No Headlines